Inhaled corticosteroids should only be used as an add-on therapy in patients with COPD and their addition to LABA maintenance therapy in these patients must be personalised, agree international respiratory experts. Tackling the much-debated topic of the efficacy, safety and positioning of ICS in the treatment of COPD, the group critically reviewed the evidence for ...
Use of ICS in COPD should be individualised say experts
By Jennie James
18 Sep 2018